New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?

E-ISSN： 1996-3181|14|5|677-686

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.14, Iss.5, 2015-06, pp. : 677-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New therapeutic targets for amyotrophic lateral sclerosis

By Kuzma-Kozakiewicz Magdalena Kwiecinski Hubert

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 127-143

Informa Healthcare

Access to resources Recommend Favorite

New therapy options for amyotrophic lateral sclerosis

By Gordon Paul Corcia Philippe Meininger Vincent

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1907-1917

Informa Healthcare

Access to resources Recommend Favorite

Management of Amyotrophic Lateral Sclerosis

By Corcia Philippe Meininger Vincent

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1037-1048

Adis International

Access to resources Recommend Favorite

Emerging drugs for amyotrophic lateral sclerosis

By Habib Ali Aamer Mitsumoto Hiroshi

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 537-558

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic advances in amyotrophic lateral sclerosis

By Louvel E. Hugon J. Doble A.

Trends in Pharmacological Sciences, Vol. 18, Iss. 6, 1997-06 ,pp. : 196-203

Elsevier

Access to resources Recommend Favorite